vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与TRANSACT TECHNOLOGIES INC（TACT）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是TRANSACT TECHNOLOGIES INC的1.2倍（$13.7M vs $11.5M），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 11.9%），TRANSACT TECHNOLOGIES INC自由现金流更多（$589.0K vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 3.5%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
CPIX vs TACT — 直观对比
营收规模更大
CPIX
是对方的1.2倍
$11.5M
营收增速更快
CPIX
高出19.1%
11.9%
自由现金流更多
TACT
多$586.0K
$3.0K
两年增速更快
CPIX
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $11.5M |
| 净利润 | $-1.4M | — |
| 毛利率 | 83.6% | 47.6% |
| 营业利润率 | -10.0% | -10.1% |
| 净利率 | -10.3% | — |
| 营收同比 | 31.1% | 11.9% |
| 净利润同比 | 25.8% | — |
| 每股收益（稀释后） | $-0.09 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXTACT
| Q4 25 | $13.7M | $11.5M | ||
| Q3 25 | $8.3M | $13.2M | ||
| Q2 25 | $10.8M | $13.8M | ||
| Q1 25 | $11.7M | $13.1M | ||
| Q4 24 | $10.4M | $10.2M | ||
| Q3 24 | $9.1M | $10.9M | ||
| Q2 24 | $9.8M | $11.6M | ||
| Q1 24 | $8.5M | $10.7M |
净利润CPIXTACT
| Q4 25 | $-1.4M | — | ||
| Q3 25 | $-1.9M | $15.0K | ||
| Q2 25 | $-740.7K | $-143.0K | ||
| Q1 25 | $1.3M | $19.0K | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-1.5M | $-551.0K | ||
| Q2 24 | $-1.1M | $-319.0K | ||
| Q1 24 | $-1.9M | $-1.0M |
毛利率CPIXTACT
| Q4 25 | 83.6% | 47.6% | ||
| Q3 25 | 88.1% | 49.8% | ||
| Q2 25 | 81.4% | 48.2% | ||
| Q1 25 | 87.8% | 48.7% | ||
| Q4 24 | 81.1% | 44.2% | ||
| Q3 24 | 85.4% | 48.1% | ||
| Q2 24 | 82.6% | 52.7% | ||
| Q1 24 | 81.5% | 52.6% |
营业利润率CPIXTACT
| Q4 25 | -10.0% | -10.1% | ||
| Q3 25 | -23.7% | 0.1% | ||
| Q2 25 | -6.9% | -1.9% | ||
| Q1 25 | 11.0% | -0.1% | ||
| Q4 24 | -17.7% | -10.3% | ||
| Q3 24 | -18.6% | -7.7% | ||
| Q2 24 | -10.4% | -3.8% | ||
| Q1 24 | -22.0% | -12.2% |
净利率CPIXTACT
| Q4 25 | -10.3% | — | ||
| Q3 25 | -23.4% | 0.1% | ||
| Q2 25 | -6.8% | -1.0% | ||
| Q1 25 | 10.7% | 0.1% | ||
| Q4 24 | -18.2% | — | ||
| Q3 24 | -17.0% | -5.1% | ||
| Q2 24 | -11.0% | -2.8% | ||
| Q1 24 | -22.9% | -9.7% |
每股收益（稀释后）CPIXTACT
| Q4 25 | $-0.09 | $-0.11 | ||
| Q3 25 | $-0.13 | $0.00 | ||
| Q2 25 | $-0.05 | $-0.01 | ||
| Q1 25 | $0.08 | $0.00 | ||
| Q4 24 | $-0.13 | $-0.80 | ||
| Q3 24 | $-0.11 | $-0.06 | ||
| Q2 24 | $-0.08 | $-0.03 | ||
| Q1 24 | $-0.14 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $31.1M |
| 总资产 | $76.8M | $44.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXTACT
| Q4 25 | $11.4M | $20.4M | ||
| Q3 25 | $15.2M | $20.0M | ||
| Q2 25 | $16.1M | $17.7M | ||
| Q1 25 | $15.1M | $14.2M | ||
| Q4 24 | $18.0M | $14.4M | ||
| Q3 24 | $17.5M | $11.3M | ||
| Q2 24 | $17.3M | $11.1M | ||
| Q1 24 | $18.5M | $10.6M |
股东权益CPIXTACT
| Q4 25 | $24.9M | $31.1M | ||
| Q3 25 | $26.1M | $31.8M | ||
| Q2 25 | $28.0M | $31.3M | ||
| Q1 25 | $28.7M | $30.9M | ||
| Q4 24 | $22.9M | $30.6M | ||
| Q3 24 | $24.8M | $38.4M | ||
| Q2 24 | $26.3M | $38.5M | ||
| Q1 24 | $27.5M | $38.6M |
总资产CPIXTACT
| Q4 25 | $76.8M | $44.8M | ||
| Q3 25 | $65.9M | $45.0M | ||
| Q2 25 | $67.9M | $44.5M | ||
| Q1 25 | $69.9M | $44.2M | ||
| Q4 24 | $75.6M | $44.0M | ||
| Q3 24 | $76.7M | $50.5M | ||
| Q2 24 | $78.5M | $50.4M | ||
| Q1 24 | $81.5M | $51.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $609.0K |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $589.0K |
| 自由现金流率自由现金流/营收 | 0.0% | 5.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | $7.6M |
8季度趋势，按日历期对齐
经营现金流CPIXTACT
| Q4 25 | $3.0K | $609.0K | ||
| Q3 25 | $187.2K | $3.6M | ||
| Q2 25 | $843.8K | $3.6M | ||
| Q1 25 | $3.9M | $-161.0K | ||
| Q4 24 | $1.9M | $2.4M | ||
| Q3 24 | $475.5K | $327.0K | ||
| Q2 24 | $-855.7K | $636.0K | ||
| Q1 24 | $-2.1M | $-1.5M |
自由现金流CPIXTACT
| Q4 25 | $3.0K | $589.0K | ||
| Q3 25 | $163.4K | $3.6M | ||
| Q2 25 | $817.3K | $3.6M | ||
| Q1 25 | $3.9M | $-171.0K | ||
| Q4 24 | $1.9M | $2.4M | ||
| Q3 24 | $460.1K | $259.0K | ||
| Q2 24 | $-862.8K | $499.0K | ||
| Q1 24 | $-2.2M | $-1.6M |
自由现金流率CPIXTACT
| Q4 25 | 0.0% | 5.1% | ||
| Q3 25 | 2.0% | 27.1% | ||
| Q2 25 | 7.5% | 25.9% | ||
| Q1 25 | 32.9% | -1.3% | ||
| Q4 24 | 18.2% | 23.2% | ||
| Q3 24 | 5.1% | 2.4% | ||
| Q2 24 | -8.8% | 4.3% | ||
| Q1 24 | -25.6% | -14.9% |
资本支出强度CPIXTACT
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.3% | 0.5% | ||
| Q2 25 | 0.2% | 0.1% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.2% | 0.6% | ||
| Q2 24 | 0.1% | 1.2% | ||
| Q1 24 | 0.5% | 1.0% |
现金转化率CPIXTACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
